Which documentation element is essential when a patient begins a new cardiac medication?

• A. Time, dose, route, patient response, vitals, adverse effects, and instructions given.
• B. Time, dose, route, patient response, vitals, cost of medication.
• C. Vitamin intake.
• D. Adverse effects and patient education provided.

Answer: (A)

When starting a new cardiac medication, a complete, safety-focused documentation set is essential. Record exactly how the drug is given: the time, the dose, and the route. This ensures correct administration and helps maintain therapeutic levels. Note the patient’s response to the medication—whether symptoms improve, worsen, or remain the same—so you can judge effectiveness and decide about continuation or adjustment. Monitor and document vitals because many cardiac drugs affect heart rate, blood pressure, and rhythm, providing objective safety data. Capture any adverse effects as they occur to recognize and manage issues early. Finally, record the instructions given to the patient so they understand dosing, timing, what to monitor, and when to seek help.

Other options fall short because they omit one or more of these critical elements, such as administration specifics, patient response, or safety monitoring, and may include irrelevant items like cost or vitamin intake.